Edition:
United States

Pluristem Therapeutics Inc (PSTI.OQ)

PSTI.OQ on NASDAQ Stock Exchange Capital Market

0.95USD
11 Dec 2018
Change (% chg)

-- (--)
Prev Close
$0.95
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
42,929
52-wk High
$1.63
52-wk Low
$0.93

Select another date:

Tue, Jun 12 2018

Photo

Israel's Pluristem sees positive results from leg pain study

TEL AVIV Israel's Pluristem Therapeutics Inc, a developer of placenta-based stem cell products, said on Tuesday it had positive results from a mid-stage study of its therapy to treat leg pain known as intermittent claudication (IC).

Israel's Pluristem sees positive results from leg pain study

TEL AVIV, June 12 Israel's Pluristem Therapeutics Inc, a developer of placenta-based stem cell products, said on Tuesday it had positive results from a mid-stage study of its therapy to treat leg pain known as intermittent claudication (IC).

Select another date: